Clonal expansion of cytotoxic CD8+ T cells in lecanemab-associated ARIA
Single-cell RNA-seq · human · 18 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Homo sapiens (human)
- Samples
- 18 samples: 18 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Clonal expansion of cytotoxic CD8⁺ T cells in lecanemab-associated ARIANature communications · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE316096_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1400587. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 18 sample titles: 18 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9444420 PBMCs, AD patient, lecanemab, control, 75-79F, E3/E4, Gene Expression
- GSM9444421 PBMCs, AD patient, lecanemab, control, 75-79F, E3/E4, CITE-seq ADT
- GSM9444422 PBMCs, AD patient, lecanemab, control, 75-79F, E3/E4, TCR VDJ
- GSM9444423 PBMCs, AD patient, lecanemab, ARIA-E, 70-74F, E3/E4, Gene Expression
- GSM9444424 PBMCs, AD patient, lecanemab, ARIA-E, 70-74F, E3/E4, CITE-seq ADT
- GSM9444425 PBMCs, AD patient, lecanemab, ARIA-E, 70-74F, E3/E4, TCR VDJ
- GSM9444426 PBMCs, AD patient, lecanemab, control, 70-74M, E4/E4, Gene Expression
- GSM9444427 PBMCs, AD patient, lecanemab, control, 70-74M, E4/E4, CITE-seq ADT
- GSM9444428 PBMCs, AD patient, lecanemab, control, 70-74M, E4/E4, TCR VDJ
- GSM9444429 PBMCs, AD patient, lecanemab, ARIA-H, 65-69M, E4/E4, Gene Expression
- GSM9444430 PBMCs, AD patient, lecanemab, ARIA-H, 65-69M, E4/E4, CITE-seq ADT
- GSM9444431 PBMCs, AD patient, lecanemab, ARIA-H, 65-69M, E4/E4, TCR VDJ
- GSM9444432 PBMCs, AD patient, lecanemab, control, 75-79F, E4/E4, Gene Expression
- GSM9444433 PBMCs, AD patient, lecanemab, control, 75-79F, E4/E4, CITE-seq ADT
- GSM9444434 PBMCs, AD patient, lecanemab, control, 75-79F, E4/E4, TCR VDJ
- GSM9444435 PBMCs, AD patient, lecanemab, ARIA-E+H, 70-74F, E4/E4, Gene Expression
- GSM9444436 PBMCs, AD patient, lecanemab, ARIA-E+H, 70-74F, E4/E4, CITE-seq ADT
- GSM9444437 PBMCs, AD patient, lecanemab, ARIA-E+H, 70-74F, E4/E4, TCR VDJ
- GSE272993 Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8 T cells [dataset 1] 360 samples shares cd8, clonal
- GSE225063 Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity 256 samples shares cd8, cytotoxic
- GSE210231 CD8+ T cell memory induced by successive SARS-CoV-2 mRNA vaccinations is characterized by shifts in clonal dominance 931 samples shares cd8, clonal
- GSE279781 CD137 agonism enhances anti-PD1 induced activation of clonally expanded CD8+ T cells in a neoadjuvant pancreatic cancer clinical trial 30 samples shares cd8, clonal
- GSE291804 Multi-omics analysis of brain metastasis elucidates obesity induced prostaglandin crosstalk in tumor microenvironment restrain CD8T cell expansion 18 samples shares cd8, expansion
- GSE317789 Single-cell and spatial profiling reveal cDC2A-CXCL13+ CD8+ T-epithelial cell crosstalk and cytotoxicity through TNFRSF9 in cutaneous and mucosal lichen planus 42 samples shares cd8, cytotoxic
- GSE285515 NKG2D blockade impairs cytotoxic CD8+ tissue resident memory T cell accumulation and attenuates severity of chronic lung allograft dysfunction after transplantation 15 samples shares cd8, cytotoxic
- GSE139555 Peripheral clonal expansion of T lymphocytes associates with tumour infiltration and response to cancer immunotherapy 32 samples shares expansion, clonal
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.